Trademarkia Logo

Canada

C$
Trademark Search in Canada
Y-PRIT

View On IC.GC.CA

Y-PRIT
SEARCHED

on 16 Apr 2024

Last Applicant/ Owned by

Y-mAbs Therapeutics, Inc

230 Park Avenue, Suite 3350New York NY 10169

US

Serial Number

2278321 filed on 20th Jun 2023

Correspondent Address

MICHELE BALLAGH

Brunet & Co.401 Bay St.Suite 1600Toronto

ONTARIO

CA

M5H2Y4

Y-PRIT

Trademark usage description

pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer. rese Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer.

Classification kind code

12

Class [042]
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technology services, namely scientific research, testing and analysis relating to the following sectors: antibodies and research and design related thereto; industrial analysis services and industrial research services, relating to the following sector: antibodies.

Classification kind code

12

Mark Details

Serial Number

2278321

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 3rd May 2024		Agent Changed
Submitted for opposition 210
on 2th May 2024		IR Correction
Submitted for opposition 22
on 16th Apr 2024		Search Recorded
Submitted for opposition 20
on 16th Apr 2024		Examiner's First Report
Submitted for opposition 223
on 16th Apr 2024		Total Provisional Refusal
Submitted for opposition 257
on 31st Aug 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 30th Aug 2023		Formalized
Submitted for opposition 1
on 30th Aug 2023		Created
Submitted for opposition 228
on 20th Jun 2023		International Registration
Submitted for opposition 30
on 20th Jun 2023		Filed